☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Dr. Susana Banerjee, Medical Oncologist at The Royal Marsden Shares Insights from the SOLO-1 P-III Trial of Lynparza in Patients w...
November 14, 2022
Akeso's Ivonescimab Receives the NMPA’s Breakthrough Therapy Designation for the Treatment of Non-Small-Cell Lung Carcinoma
November 14, 2022
Genentech's Gantenerumab Missed Primary Endpoints in P-III (GRADUATE I & II) Studies for Early Alzheimer’s Disease
November 14, 2022
Alvotech and Cipla Receive Marketing Authorization for AVT02 (biosimilar, adalimumab) in Australia
November 14, 2022
Indivior to Acquire Opiant Pharmaceuticals for ~$145M
November 14, 2022
OncoSec Reports P-II (KEYNOTE-695) Trial Results of TAVO-EP + Keytruda (pembrolizumab) for Advanced Melanoma
November 14, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions